Tedco awards $600K to tech firms - Phoenix Business Journal:

vorotintseyqah.blogspot.com
The money was granted in collaboration withthe U.S. Army Medicall Research and Materiel Commandr and the throughthe Ft. Detrick Technology Transfert Initiative. The purpose of the technology transfer prograk is to raise awareness of new and developing technologies and funding them to transitionn as viable projectsfor follow-omn funding in the market place. Each company that receivee funding was awardedapproximately $50,000 betweebn March 2008 and May making up the initiative’s second round of financial awards since its $750,009 program extension. The funds for the program’sz second phase were secured by Sen. Barbaraw Mikulski, D-Md., and Rep. Roscoe G. Bartlett, R-Md.
“Thre [Ft. Detrick Technology Transfer Initiative] program is enabling area businessess to harness the technologies being developed at Fort Detrick and applyg them to thecommercial sector,” said Mikulski. “Thisx will lead to new productds that have the power to create jobs and save Mikulski announced the first phase of the tech transfer prograj in March 2005 when 11 companiesreceivef funding. in Rockville: The companyu is developing a health care technology callexdmiTag system, which is a scalable wireless sensorf solution for improving patientf flow.
in Frederick: The company is developinvg a technology called the GeNov a Screento identify, isolate, and produc e antibody-like molecules. in Rockville: The company is developing an on-demand biotechj products including a combination vaccine against plaguand anthrax. BioAssay Works LLC in Ijamsville: The company is developing a lateral-flow visuall diagnostic test to detecg and differentiate single sample multiplepathogenicc poxviruses, including variola, vaccinia, and in Catonsville: The company is safety-testing a medicall product called ClotFoam, which is a non-compressible, intracavitaryy hemostatic agent.
CynerGene IDMP in Frederick: The companh is developing, validating and implementing a supplementa l diagnosisof Malaria, HIV, and Dengue usingt its Infectious Disease Multiplex Panel which could allow for creatio n of biosensors. LLC in The company is developing required components and systejm framework to enable conversational interfaces for telemedicine Such tools would allow professional medics touse voice, gesture, and other human-- computer interactions to access and document information in electronic medicalo records.
in Rockville: The compan y is developing technology to preserve mammalian cellss in dried format that can easiltybe re-hydrated for a variety of LLC in Frederick: The company is evaluating the effecty of Imagilin patented probiotics as a food supplement to enhance the immune responsiveness of guinea pigs upon immunizatio or challenge with virulent The evaluation will suggesty the ability of Imagilin patented probiotics to enhance the immunization of a in Baltimore: The company is developing micropatterned substrate s for viral infectivity assays. Juxtopia in The company is customizing its Wearable Assistance and SituationaoAwareness (WASA) goggles and service to allow U.S.
Army combaty medics to access and documeny information to electrical medical recordsvia hands-frede voice-requests and voice-responses. in Baltimore: The company is developing cell therapies to treatf brain and spinalcord injuries.